INFLUENCE OF SACUBITRIL/VALSARTAN ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH REDUCED EJECTION FRACTION
2017
Background: Type 2 diabetes (T2DM) is an independent risk factor for heart failure progression. Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, improves morbidity and mortality in patients with heart failure with reduced ejection fraction (HFrEF) and was shown to improve
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI